Intrinsic Value of S&P & Nasdaq Contact Us

Aerovate Therapeutics, Inc. AVTE

NASDAQ Global Market

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.00
+385.1%

Aerovate Therapeutics, Inc. (AVTE) current share price is $2.68. The gold spot price is $4,825.20 per troy ounce. Using the formula: AVTE in gold = $2.68 × 31.1035 ÷ $4,825.20 = 0.0173 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of AVTE when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding AVTE shares over the measured period.

AVTE in US Dollars
Gold in US Dollars
AVTE in Gold (grams per share)

Real Wealth Growth Rate

AVTE
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{AVTE}_{\text{gold}}(t) = \frac{P_{\text{AVTE}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{AVTE}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{AVTE}_{\text{gold}}^{(T)}}{\text{AVTE}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{AVTE}_\text{gold}^{(0)}$ = initial gold-price, $\text{AVTE}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

OPT
OPT
Opthea Limited
$3.41
+1.49%
MLYS
MLYS
Mineralys Therapeutics, Inc.
$27.32
+0.59%
RZLT
RZLT
Rezolute, Inc.
$3.56
-1.36%
ADAG
ADAG
Adagene Inc.
$3.81
-0.78%
ANTX
ANTX
AN2 Therapeutics, Inc.
$2.98
-1.00%
ACRV
ACRV
Acrivon Therapeutics, Inc. Common Stock
$1.64
+1.86%
ANEB
ANEB
Anebulo Pharmaceuticals, Inc.
$0.50
-0.04%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message